The Importance of Clinical Breast Examinations in Breast Cancer Diagnosis
![]()
Breast cancer is the most commonly diagnosed cancer among women worldwide, with nearly 2.1 million new cases and 630,000 deaths globally reported in 2018 alone. This high mortality rate is attributed to the late diagnosis of the disease. Early detection and prompt treatment of breast cancer are essential to improving survival rates and reducing morbidity. Breast cancer can be diagnosed through various methods, including mammography, ultrasound, magnetic resonance imaging (MRI), and clinical breast examinations (CBEs).
CBE is a physical examination of the breast tissue by a healthcare professional, including visual inspection and palpation of the breast tissue and the lymph nodes in the armpit and collarbone areas. A CBE can be performed by a breast specialist, gynecologist, primary care provider, or a trained nurse. A CBE is a useful tool in detecting breast cancer, especially in asymptomatic women who may not have any noticeable physical changes in their breast tissue.
Benefits of Clinical Breast Examinations
CBEs offer several benefits in the detection of breast cancer. Firstly, CBEs are non-invasive and do not expose the patient to any harmful radiation. This makes CBEs an ideal screening option for women who are pregnant or breastfeeding, for whom mammography and other imaging tests may not be recommended. Secondly, CBEs are cost-effective and widely available, making them accessible to women who may not have access to mammography or other more specialized diagnostic tests. CBEs can also be performed as part of routine physical examinations, meaning women can be screened for breast cancer during their regular medical check-ups.
Thirdly, CBEs are sensitive in detecting breast lumps that may not be visible on mammography or other imaging tests, especially in younger women who may have denser breast tissue that obscures the lump. Breast cancer can occur at any age, and CBEs are useful in detecting breast cancer in women under the age of 40 who may not be eligible for mammography. Additionally, CBEs can detect breast cancer in women who have already had a history of breast cancer or who have other risk factors for developing breast cancer, such as a family history of the disease.
Limitations of Clinical Breast Examinations
While CBEs offer several benefits in detecting breast cancer, they also have some limitations. Firstly, CBEs are operator-dependent and require a skilled clinician who has undergone specialized training to perform the examination accurately. As such, the accuracy of CBEs can vary depending on the clinician's training and experience, leading to variations in the detection of breast cancer. Secondly, CBEs have a higher rate of false positives, where an abnormal lump is detected, but the biopsy confirms that it is not cancerous. This can lead to more invasive diagnostic tests and unnecessary stress for the patient.
When to Get a Clinical Breast Examination
The American Cancer Society recommends that women undergo a CBE every three years between the ages of 20 and 39 and then yearly after age 40. However, women who have a personal or family history of breast cancer or have other risk factors may need more frequent CBEs or additional tests, such as mammography or MRI. Women should discuss their individual risk factors with their healthcare provider to determine the appropriate screening schedule.
Conclusion
In conclusion, CBEs are an essential tool in detecting breast cancer, especially in asymptomatic women and those who may not have access to mammography or other imaging tests. While CBEs have some limitations in accuracy and the potential for false positives, they offer several benefits, including being non-invasive, cost-effective, and widely available. Women should discuss their individual risk factors with their healthcare provider to determine the appropriate screening schedule, including CBEs and other diagnostic tests. By detecting breast cancer early through regular screening, women can receive prompt treatment, leading to better outcomes and improved survival rates.